Related Experiment Video
Updated: Feb 7, 2026

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
Published on: August 30, 2019
Tanshinone IIA activates autophagy to reduce liver ischemia-reperfusion injury by MEK/ERK/mTOR pathway
Abstract:
Autophagy is a highly conserved cell program in eukaryotic cells, which plays an important role for cells to deal with adverse external stimuli such as ischemia-reperfusion. Tanshinone IIA (TanIIA) is well known for its protective effect on myocardial disease, and it is know that it also could regulate autophagy in different cells. As this has not yet been shown for hepatocytes, using a mice liver ischemia-reperfusion model, we detected the role of TanIIA in regulating autophagy and the subsequent protective effects on hepatocytes. Our data showed that TanIIA pretreatment could significantly enhance autophagy by the MEK/ERK/mTOR pathway in hepatocytes after liver ischemia-reperfusion, and the enhanced autophagy decreased ROS generation by clearing damaged mitochondria, providing a protective effect on liver ischemia-reperfusion. This protective effect is manifested as reduced serum enzyme levels, reduced liver tissue damage, decreased inflammatory cell infiltration, decreased inflammatory cytokines and reduced hepatocyte apoptosis. In brief, moderate TanIIA utilization might be a potential treatment approach for clinically liver ischemia-reperfusion.
Insights
Tanshinone IIA enhances autophagy in liver cells during ischemia-reperfusion injury by activating the MEK/ERK/mTOR pathway. This process reduces oxidative stress and protects liver cells, suggesting TanIIA as a potential therapeutic for liver injury.
Area of Science:
- Cell Biology
- Hepatology
- Pharmacology
Background:
- Autophagy is a crucial cellular process for managing stress, including ischemia-reperfusion (I/R) injury.
- Tanshinone IIA (TanIIA) is known to affect autophagy and protect against myocardial disease.
- The role of TanIIA in regulating autophagy in hepatocytes during I/R injury remains unexplored.
Purpose of the Study:
- To investigate the effect of Tanshinone IIA (TanIIA) on autophagy in hepatocytes following liver ischemia-reperfusion (I/R) injury.
- To elucidate the molecular pathway involved in TanIIA-mediated autophagy regulation.
- To assess the protective efficacy of TanIIA against liver I/R injury.
Main Methods:
- Establishment of a mouse model for liver ischemia-reperfusion (I/R) injury.
- Pretreatment of mice with Tanshinone IIA (TanIIA).
- Analysis of autophagy markers, MEK/ERK/mTOR pathway activation, reactive oxygen species (ROS) generation, and hepatocyte apoptosis.
Main Results:
- TanIIA pretreatment significantly enhanced autophagy in hepatocytes post-liver I/R.
- TanIIA activated the MEK/ERK/mTOR pathway, leading to increased autophagy.
- Enhanced autophagy reduced ROS generation by clearing damaged mitochondria, mitigating liver injury, decreasing inflammatory markers, and reducing hepatocyte apoptosis.
Conclusions:
- Tanshinone IIA (TanIIA) effectively enhances autophagy in hepatocytes via the MEK/ERK/mTOR pathway during liver ischemia-reperfusion (I/R) injury.
- The TanIIA-induced autophagy provides significant protection against liver I/R injury by reducing oxidative stress and inflammation.
- Moderate use of TanIIA presents a potential therapeutic strategy for clinical management of liver I/R injury.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Methods of reducing fever
Pharmacological Methods of Reducing Fever:

